Nautilus Biotechnology (NAUT) Cash & Equivalents (2020 - 2026)
Nautilus Biotechnology (NAUT) reported Cash & Equivalents of $13.17 million for Q2 2026, down 61.8% from $34.46 million a year earlier and down 10.0% from the prior quarter.
Powered by 
Analysis
Nautilus Biotechnology (NAUT) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Nautilus Biotechnology posted Cash & Equivalents of $12.39 million, down 55.2% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -19.5% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $27.65 million in FY2024 (+42.5%), $19.4 million in FY2023 (-83.1%), $114.52 million in FY2022 (-38.3%) and $185.62 million in FY2021 (+407.1%).
- Five-year quarterly Cash & Equivalents spans a low of $4.41 million in Q3 2024 and a high of $210.35 million in Q2 2022.
- Year over year, Cash & Equivalents has now declined in each of the last three quarters, with growth averaging 35.6% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2025 (growth of 441.5%); the low point was Q3 2024 (a decline of 94.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.63 million (Q1 2026), $12.39 million (Q4 2025) and $23.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.17 Bn | 228.32 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 179.42 Bn | 150.51 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 161.98 Bn | 145.80 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 156.76 Bn | 137.18 Bn | 2.08 Bn | 2.98 Bn |
| 5 | Medtronic | 122.13 Bn | 88.00 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 117.84 Bn | 103.96 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 66.19 Bn | 61.20 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Becton Dickinson | 54.16 Bn | 51.31 Bn | 2.32 Bn | 708.00 Mn |
| 9 | Edwards Lifesciences | 51.35 Bn | 35.47 Bn | 1.35 Bn | 2.91 Bn |
| 10 | Nautilus Biotechnology | 412.21 Mn | -2.53 Mn | 175,000.00 | 13.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.17 Mn |
| Mar 31, 2026 | 14.63 Mn |
| Dec 31, 2025 | 12.39 Mn |
| Sep 30, 2025 | 23.88 Mn |
| Jun 30, 2025 | 34.46 Mn |
| Mar 31, 2025 | 33.24 Mn |
| Dec 31, 2024 | 27.65 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 24.89 Mn |
| Mar 31, 2024 | 25.73 Mn |
| Dec 31, 2023 | 19.40 Mn |
| Sep 30, 2023 | 74.10 Mn |
| Jun 30, 2023 | 72.14 Mn |
| Mar 31, 2023 | 88.51 Mn |
| Dec 31, 2022 | 114.52 Mn |
| Sep 30, 2022 | 188.93 Mn |
| Jun 30, 2022 | 210.35 Mn |
| Mar 31, 2022 | 188.62 Mn |
| Dec 31, 2021 | 185.62 Mn |
| Sep 30, 2021 | 190.24 Mn |
API Access
Nautilus Biotechnology Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NAUT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NAUT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NAUT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();